About the Authors
- Marieke M. J. Herenius
-
* E-mail: m.m.herenius@amc.uva.nl
Affiliation Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- Ana S. F. Oliveira
-
Affiliations Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- Carla A. Wijbrandts
-
Affiliation Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- Daniëlle M. Gerlag
-
Affiliation Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- Paul P. Tak
-
Current address: Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands and GlaxoSmithKline, Stevenage, United Kingdom
Affiliation Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- Maria C. Lebre
-
Affiliations Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Competing Interests
The study was financed by Abbott Laboratories. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MH AO CW DG PT ML. Performed the experiments: MH AO CW ML. Analyzed the data: MH ML. Contributed reagents/materials/analysis tools: MH AO CA DG PT ML. Wrote the paper: MH ML PT. Obtained ICF: MH CW DG.